Voltar
Artigo
BIBTEX RIS

A Phase II Multicenter Study of Visilizumab, Humanized Anti-CD3 Antibody, to Treat Steroid-Refractory Acute Graft-versus-Host Disease

2005; Elsevier BV; Volume: 11; Issue: 6 Linguagem: Inglês

10.1016/j.bbmt.2005.03.002

ISSN

1523-6536

Autores

Paul A. Carpenter, James N. Lowder, Laura Johnston, Haydar Frangoul, H. Jean Khoury, Pablo Parker, Keith R. Jerome, Jeannine S. McCune, Barry E. Storer, Paul J. Martin, Frederick R. Appelbaum, Rafat Abonour, Peter Westervelt, Claudio Anasetti,

Tópico(s)

Cytomegalovirus and herpesvirus research

Referência(s)